Barbara A. Konkle

Mohamed Sorror, M.D., M.Sc., is an esteemed hematologist and oncologist based in Seattle, WA, specializing in the treatment of patients with hematological malignancies. Dr. Sorror is known for his patient-centered approach, encouraging active participation in treatment decisions and providing compassionate care akin to that for his own family members. With a strong background in clinical and laboratory research, Dr. Sorror holds leadership positions in hematology research at national and international levels. In addition to his professional commitments, he enjoys spending time with his family, participating in marathons, hiking, snowshoeing, and exploring new travel destinations.Generated from the website

Cecilia Cs Yeung, M.D. is a dedicated hematopathologist at the Fred Hutchinson Cancer Center in Seattle, WA, specializing in infectious diseases and transplant surgery. Dr. Yeung is committed to providing patients with accurate diagnoses and timely care, striving to make a positive impact on their health journeys. With a background in molecular genetics and pathology, Dr. Yeung is also an assistant professor of Pathology at the University of Washington, where she leads efforts to expand molecular pathology education and conducts research to discover biomarkers for improved diagnosis and treatment outcomes. In her free time, she enjoys activities such as bicycling, pottery, and hiking.Generated from the website

Steven Aaron Pergam, M.D., M.P.H. is a board-certified physician specializing in epidemiology and infectious diseases, serving as the associate director of Infection Control at Fred Hutchinson Cancer Center in Seattle, WA. With a focus on preventing infections in immunocompromised populations, Dr. Pergam is dedicated to fostering collaborative relationships with his patients to achieve optimal health outcomes. His extensive research background includes projects on nosocomial bacterial infections and respiratory viruses in cancer patients, as well as studies on natural killer cell-associated outcomes post-transplant. Dr. Pergam's commitment to patient care and ongoing research efforts underscores his dedication to advancing the field of infectious diseases and improving healthcare for vulnerable populations.Generated from the website